Applied Dna Sciences Inc (APDN) concluded trading on Wednesday at a closing price of $2.00, with 7.25 million shares of worth about $14.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -96.99% during that period and on Wednesday the price saw a gain of about 14.94%. Currently the company’s common shares owned by public are about 1.10M shares, out of which, 1.10M shares are available for trading.
Stock saw a price change of -37.01% in past 5 days and over the past one month there was a price change of -76.12%. Year-to-date (YTD), APDN shares are showing a performance of -80.39% which decreased to -99.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.71 but also hit the highest price of $522.00 during that period. The average intraday trading volume for Applied Dna Sciences Inc shares is 132.74K. The stock is currently trading -64.65% below its 20-day simple moving average (SMA20), while that difference is down -74.29% for SMA50 and it goes to -91.40% lower than SMA200.
Applied Dna Sciences Inc (NASDAQ: APDN) currently have 1.10M outstanding shares and institutions hold larger chunk of about 39.58% of that.
The stock has a current market capitalization of $2.21M and its 3Y-monthly beta is at 0.83. It has posted earnings per share of -$285.87 in the same period. It has Quick Ratio of 4.53 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APDN, volatility over the week remained 25.88% while standing at 14.38% over the month.
Stock’s fiscal year EPS is expected to rise by 73.63% while it is estimated to increase by 77.08% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by ROTH Capital on February 12, 2021 offering a Buy rating for the stock and assigned a target price of $24 to it. Coverage by H.C. Wainwright stated Applied Dna Sciences Inc (APDN) stock as a Buy in their note to investors on January 14, 2021, suggesting a price target of $14 for the stock. On December 18, 2020, H.C. Wainwright Reiterated their recommendations, while on July 20, 2020, H.C. Wainwright Reiterated their ratings for the stock with a price target of $22. Stock get a Buy rating from H.C. Wainwright on July 02, 2020.
